MYUNGMOON Pharm co.,Ltd (KRX:017180)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,286.00
+90.00 (7.53%)
Sep 1, 2026, 3:30 PM KST

MYUNGMOON Pharm co.,Ltd Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
24,0815,8364,3927,9624,8586,813
Short-Term Investments
2152953503,6505,0653,620
Trading Asset Securities
9.0414.3215.4152.6561.6783.95
Cash & Short-Term Investments
24,3056,1454,75811,6649,98410,517
Cash Growth
180.03%29.17%-59.21%16.83%-5.06%-19.65%
Accounts Receivable
46,15242,86838,09133,48929,45627,530
Other Receivables
3,4353,6704,0444,2433,6062,171
Receivables
49,78746,53842,17238,84634,67330,281
Inventory
43,77738,72432,68530,28025,66026,032
Prepaid Expenses
245.13118.66210.07189.83184.71504.29
Other Current Assets
293.43546.14505.1455.72205.58132.32
Total Current Assets
118,40892,07280,32981,43670,70767,466
Property, Plant & Equipment
135,738165,856161,994140,196141,777142,861
Long-Term Investments
2,7913,6893,4311,5404,4573,245
Other Intangible Assets
496.49472.33528.86267.49318.47247.39
Long-Term Deferred Tax Assets
4,5764,7676,1758,1098,1684,273
Other Long-Term Assets
37,8445,2915,2225,0015,0225,170
Total Assets
300,162272,455257,988236,549230,450223,263

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
18,54815,37917,38216,74615,67713,633
Accrued Expenses
18,44618,09017,03116,34911,84812,124
Short-Term Debt
49,89051,10642,11474,60773,50375,657
Current Portion of Long-Term Debt
15,0754,0439,6861,9071,3061,269
Current Portion of Leases
419.33350.63376.13922.991,0451,249
Current Income Taxes Payable
25.0464.2747.47-118.42164.35
Other Current Liabilities
8,9967,3306,0235,8407,3258,992
Total Current Liabilities
111,39996,36392,660116,373110,821113,088
Long-Term Debt
21,17642,64635,25512,5846,0924,957
Long-Term Leases
587.49488.1974.33460.21,212998.7
Pension & Post-Retirement Benefits
20,38419,52617,73413,20513,26613,812
Long-Term Deferred Tax Liabilities
6,7936,7936,4363,5213,5213,706
Other Long-Term Liabilities
37,1822,1822,7071,652270.67827.67
Total Liabilities
197,523167,999154,865147,794135,182137,389

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
16,97716,97716,97716,97716,97716,977
Additional Paid-In Capital
34,74535,17835,17835,17835,17877,313
Retained Earnings
877.122,976564.416,03111,425-39,976
Treasury Stock
-94.43-1,471-1,471-1,215-540.01-540.01
Comprehensive Income & Other
45,08245,08245,60326,48326,48326,483
Total Common Equity
97,58698,74196,85183,45389,52280,257
Minority Interest
5,0535,7166,2715,3025,7455,617
Shareholders' Equity
102,640104,457103,12388,75595,26785,874
Total Liabilities & Equity
300,162272,455257,988236,549230,450223,263

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
87,14898,63487,50590,48283,15784,130
Net Cash (Debt)
-62,842-92,489-82,748-78,818-73,173-73,614
Net Cash Growth
------
Net Cash Per Share
-1867.13-2766.78-2481.48-2340.26-2164.50-2177.55
Filing Date Shares Outstanding
34.0833.4333.4333.5333.8133.81
Total Common Shares Outstanding
34.0833.4333.4333.5333.8133.81
Working Capital
7,009-4,291-12,330-34,937-40,115-45,622
Book Value Per Share
2863.492953.802897.282489.112648.132374.06
Tangible Book Value
97,09098,26896,32283,18689,20480,010
Tangible Book Value Per Share
2848.922939.672881.462481.142638.712366.74
Land
76,903100,264100,26474,39774,39774,726
Buildings
47,57561,19761,19761,54558,19458,325
Machinery
36,07534,68233,26632,32530,82829,991
Construction In Progress
10,0878,4022,1912,1913,4182,365